Day: July 29, 2024

AMG Reports Financial and Operating Results for the Second Quarter and First Half of 2024

Written by Customer Service on July 29, 2024. Posted in Public Companies.

Company reports EPS of $2.26, Economic EPS of $4.67 in the second quarter of 2024Net income (controlling interest) of $226 million, Economic Net Income (controlling interest) of $343 million in the first half of the year Economic Earnings per share of $10.06 in the first half of the year, increased 17% year-over-year Positive net client cash flows in the second quarter, driven by continued strength in private markets fundraising Repurchased $327 million in common stock, bringing total share repurchases to $477 million in the first half of the yearWEST PALM BEACH, Fla., July 29, 2024 (GLOBE NEWSWIRE) — AMG, a strategic partner to leading independent investment management firms globally, today reported its financial and operating results for the second quarter and six months ended June 30, 2024. Jay C. Horgen, President and Chief...

Tilray’s Aphria RX Receives Cannabis Trading License in Germany, Significantly Expanding Commercial Growth Opportunities

Written by Customer Service on July 29, 2024. Posted in Public Companies.

NEUMÜNSTER, Germany, July 29, 2024 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global leader in medical cannabis research, cultivation, production, and distribution, today announced that Aphria RX GmbH (“Aphria RX”) has received a trading license, which will allow it to sell and distribute a broad range of medical cannabis products to pharmacies, hospitals, and medical wholesalers throughout Germany. “This milestone of Aphria RX obtaining both its new cultivation license as well as its trading license further expands Tilray’s leadership in medical cannabis research, cultivation, production and distribution in Germany and once again proves our commitment to be one of the most responsible, trusted and market leading cannabis companies in the world with a portfolio of innovative and high-quality...

Glass Lewis Recommends Asensus Surgical Stockholders Vote “FOR” Proposals Relating to Proposed Merger with KARL STORZ

Written by Customer Service on July 29, 2024. Posted in Mergers And Acquisitions.

RESEARCH TRIANGLE PARK, N.C., July 29, 2024 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, announced today that a leading independent proxy advisory firm, Glass, Lewis & Co. (“Glass Lewis”), has recommended that Asensus Surgical stockholders vote “FOR” all proposals relating to the pending merger transaction with KARL STORZ Endoscopy-America, Inc. (“KARL STORZ”). The vote will take place at the Company’s upcoming Special Meeting of Stockholders to be held virtually at 10:00 a.m. Eastern Time on August 7, 2024. Glass Lewis is widely recognized as a leading independent voting and corporate governance advisory firm. Their analysis and recommendations are meaningful for many major institutional investment firms, mutual funds and fiduciaries...

Integra LifeSciences Reports Second Quarter 2024 Financial Results

Written by Customer Service on July 29, 2024. Posted in Earnings Releases And Operating Results.

PRINCETON, N.J., July 29, 2024 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2024. Second Quarter 2024 HighlightsSecond quarter revenues of $418.2 million increased 9.7% on a reported basis and 2.3% on an organic basis compared to the prior year. Revenue increased 0.3% on an organic basis excluding Boston.Second quarter GAAP earnings per diluted share of $(0.16), compared to $0.05 in the prior year; adjusted earnings per diluted share of $0.63, compared to $0.71 in the prior year.Early integration success with the Acclarent ENT acquisition.Announced plans to focus relaunch of SurgiMend® and PriMatrix® at new state-of-the-art manufacturing facility in Braintree, Massachusetts,...

Provident Financial Holdings Reports Fourth Quarter and Fiscal Year 2024 Results

Written by Customer Service on July 29, 2024. Posted in Earnings Releases And Operating Results.

Net Income of $1.95 Million in the June 2024 Quarter Net Interest Margin of 2.74% in the June 2024 Quarter Loans Held for Investment of $1.05 Billion at June 30, 2024, Down 2% from June 30, 2023 Total Deposits of $888.3 Million at June 30, 2024, Down 7% from June 30, 2023 Non-Performing Assets to Total Assets Ratio of 0.20% at June 30, 2024 Non-Interest Expenses Remain Well Controlled RIVERSIDE, Calif., July 29, 2024 (GLOBE NEWSWIRE) — Provident Financial Holdings, Inc. (“Company”), NASDAQ GS: PROV, the holding company for Provident Savings Bank, F.S.B. (“Bank”), today announced earnings for the fourth quarter and fiscal year ended June 30, 2024. The Company reported net income of $1.95 million, or $0.28 per diluted share (on 6.89 million average diluted shares outstanding) for the quarter ended June 30, 2024, up eight percent...

SpringWorks Therapeutics Appoints Dr. Martin Mackay to its Board of Directors

Written by Customer Service on July 29, 2024. Posted in Public Companies.

STAMFORD, Conn., July 29, 2024 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced the appointment of Martin Mackay, Ph.D. to the Company’s Board of Directors. Dr. Mackay is a highly accomplished research and development (R&D) executive with more than 30 years of pharmaceutical and biotech R&D experience, including leadership roles at Pfizer, AstraZeneca and Alexion. “Martin is a proven industry leader whose experience in developing and delivering novel treatments to patients in need is exceptional,” said Saqib Islam, Chief Executive Officer of SpringWorks. “His expertise in rare diseases and unique perspectives leading multiple Research and Development organizations across the globe will be extremely...

Brown & Brown, Inc. enters into an agreement to acquire Quintes Holding B.V.

Written by Customer Service on July 29, 2024. Posted in Mergers And Acquisitions.

DAYTONA BEACH, Fla., July 29, 2024 (GLOBE NEWSWIRE) — J. Scott Penny, chief acquisitions officer of Brown & Brown, Inc. (NYSE:BRO), Aquiline Capital Partners, Gijsbert van de Nieuwegiessen and the management ownership team of Quintes Holding B.V. (“Quintes”), today announced that the parties have entered into an agreement to acquire the Quintes insurance operations. The transaction is expected to close in the fourth quarter of 2024, subject to certain closing conditions, including the receipt of required regulatory approvals for the acquisition. Quintes was founded in 2012 by Gijsbert van de Nieuwegiessen and is one of the largest independent insurance brokers in the Netherlands. Quintes serves approximately 200,000 customers across its three main divisions: broking, MGA and pension business. Headquartered in Waardenburg,...

Correction: Nokia Corporation: Repurchase of own shares on 26.07.2024

Written by Customer Service on July 29, 2024. Posted in Public Companies.

Nokia CorporationStock Exchange Release29 July 2024 at 12:00 EET Correction: Nokia Corporation: Repurchase of own shares on 26.07.2024 Correction to Nokia Oyj’s stock exchange release regarding repurchase of own shares on 26 July 2024. In the English version of the release, total weighted average price per share was misreported. Below the corrected release. Espoo, Finland – On 26 July 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 1,385,661 3.53CEUX 739,517 3.54BATE – –AQEU – –TQEX – –Total 2,125,178 3.53* Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors...

Aktsiaselts Infortar Investor Webinar introducing the results of the Q2 2024

Written by Customer Service on July 29, 2024. Posted in Public Companies.

Infortar will organize a webinar for investors on 5 August 2024 at 12:00 (EET) in Estonian and at 14:00 (EET) in English to introduce the second quarter 2024 results. The webinar will be attended by the Managing Director of Infortar Martti Talgre and Head of Investor Relations Kadri Laanvee. The webinar is open to everyone and takes place without registration of participants. The webinar will be hosted on the Microsoft Teams platform. Please note that to participate, no prior registration is required, and no reminder of the webinar will be sent. You can either participate by joining from your web browser or via Microsoft Teams application. When using a mobile device to join the webinar, you first need to download the Microsoft Teams application from either Play Store or App Store, depending on your device’s software. Please join the webinar...

Regenx Tech to Participate in Investor Conferences and Provides Corporate Update

Written by Customer Service on July 29, 2024. Posted in Public Companies.

EDMONTON, Alberta, July 29, 2024 (GLOBE NEWSWIRE) — Regenx Tech Corp. (the “Company” or “Regenx”) (CSE: RGX) (OTCQB: RGXTF) (FSE: YRS WKN:A2DSW3) announces participation in upcoming investor conferences and an update on operations. Investor Conferences The Company has accepted invitations to participate in two upcoming investor conferences in the month of August. On August 14, 2024, Regenx’s Don Weatherbee will be presenting at the Sidoti Micro Cap Virtual Investor Conference. For over two decades, Sidoti has been a premier provider of independent securities research focused on small and micro-cap companies and the institutions that invest in their securities. Their investor conferences have emerged as a leading forum for interaction between small and micro-cap issuers and investors. On August 29, 2024, Don Weatherbee will also...

Day: July 29, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals